Adiponectin orchestrates multiple biological functions to inhibit cancer progression, and has been shown to inhibit cell proliferation via the ERK1/2-MAPK pathway in T47D cells and inhibited secondary tumor development in adjacent fat pads [68]. Here, ADIPOQ is linked to neoplasm.